This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
A novel experimental vaccine against the nipah virus has succeeded in its first major test in humans; it has been shown to be ...
Flu activity has surged in many parts of the Northern Hemisphere, driven primarily by a newly emerged H3N2 strain known as ...
Researchers used AI to identify an mpox protein that triggers a strong immune response in mouse models. | Drug Discovery And ...
13d
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
The study evaluated GEO-CM04S1 in the K18-hACE2 lethal mouse model, comparing immune responses and efficacy to experimental MVA-vectored vaccine constructs expressing spike alone (S) or nucleocapsid ...
A novel AI model helped find a key protein, named OPG153, in monkeypox virus, which could lead to cheaper and simple vaccine or a new antibody drug design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback